Efficacy and Safety Results for Pembrolizumab in Previously Treated Gastric Cancer

June 13, 2017
Charles S. Fuchs, MD, MPH

Charles S. Fuchs, MD, MPH, professor of Medicine, director, Yale Cancer Center, and physician-in-chief, Smilow Cancer Hospital, discusses efficacy and safety results for pembrolizumab (Keytruda) monotherapy in patients with previously treated advanced gastric cancer.